Founder, President & CEO

How to navigate the whisky cask boom

Inhibikase Therapeutics Announces Appointment of David McIntyre as Chief Financial Officer

Braeburn gets FDA approval for opioid use disorder drug after more than 4-year battle

FDA clears Braeburn's long-acting Brixadi to treat opioid use disorder

Key Account Manager

Braeburn is dedicated to delivering solutions for people living with opioid use disorder. The Key Account Manager will educate Healthcare Professionals about Braeburn’s products and ensure they are informed about clinical aspects and access resources, while achieving sales objectives and managing accounts effectively.

Sign up with Google

Sign in with Google